✦ LIBER ✦

Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans

✍ Scribed by Ingrid Nilsson; Lina Liskowski; Torgny Nilsson

Book ID: 119043048
Publisher: Elsevier Science
Year: 1976
Tongue: English
Weight: 370 KB
Volume: 8
Category: Article
ISSN: 0090-4295
DOI: 10.1016/0090-4295(76)90335-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Testosterone binding proteins in benign

Testosterone binding proteins in benign and malignant human prostatic tissue

✍ F.K. Habib; M.R.G. Robinson; P.H. Smith; S.R. Stitch 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Androgen, estrogen and progestogen recep

Androgen, estrogen and progestogen receptor binding in human benign prostatic hyperplasia (BPH)

✍ N Bashirelahi; S. Ganesan; J.D. Young Jr. 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Metabolism of androgens in human benign

Metabolism of androgens in human benign prostatic hyperplasia: Aromatase and its inhibition

✍ Wilfried Bartsch; Hartmut Klein; Hans-Jörg Stürenburg; Klaus-Dieter Voigt 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 824 KB

Immunocytochemical Detection of the Andr

Immunocytochemical Detection of the Androgen Receptor In Fine Needle Aspirates From Benign and Malignant Human Prostate

✍ J. BROLIN; T. LÖWHAGEN; L. SKOOG 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

Specific binding of [3H]-methyltrienolon

Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH)

✍ Jacques Asselin; Réjean Mélançon; Yves Gourdeau; Fernand Labrie; Claude Bonne; J 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 389 KB

Soluble and nuclear type I and II androg

Soluble and nuclear type I and II androgen-binding sites in benign hyperplasia and cancer of the human prostate

✍ Castagnetta, L. ;Carruba, G. ;Fecarotta, E. ;Lo Casto, M. ;Cusimano, R. ;Pavone- 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 627 KB

This paper presents an approach for the assessment of the androgen receptor (AR) status in benign prostatic hyperplasia (BPH) and prostate cancer (PCa) tissues. Evaluation of AR was carried out in both soluble and nuclear fractions by a standard competition method, using tritiated mibolerone as radi